Related Experiment Videos
[Membrane-destabilizing processes as the universal basis of inflammation]
Summary
Active pyelonephritis and surgical stress alter red blood cell membranes. Dimephosphone demonstrated a membrane-stabilizing effect, reducing inflammation and improving kidney function in patients with kidney inflammation.
Area of Science:
- Nephrology
- Biochemistry
- Cell Biology
Background:
- Active pyelonephritis and surgical stress induce significant structural and functional changes in erythrocytic membranes.
- These changes include alterations in cholesterol, oxidized phospholipids, and cation adenosine triphosphatase activity.
- The observed changes are more pronounced during the active phase of chronic pyelonephritis.
Purpose of the Study:
- To investigate the effects of active pyelonephritis and operative stress on erythrocytic membrane properties.
- To explore the potential role of bacterial kidney inflammation in these membrane alterations.
- To evaluate the therapeutic efficacy of dimephosphone as a membrane-stabilizing agent.
Main Methods:
- Analysis of structural and functional changes in erythrocytic membranes.
- Assessment of lipid composition, including cholesterol and phospholipids.
- Measurement of cation adenosine triphosphatase activity.
- Clinical evaluation of inflammation and renal function.
Main Results:
- Elevated cholesterol and oxidized phospholipids, along with altered cation adenosine triphosphatase activity, were observed in erythrocytic membranes during active pyelonephritis and operative stress.
- Minor lipid structural changes in surgical patients correlated with an uneventful postoperative period.
- Adjuvant dimephosphone therapy exhibited a significant membrane-stabilizing effect.
Conclusions:
- Bacterial inflammation in the kidneys and urinary tracts may be linked to observed shifts in erythrocytic membrane composition and function.
- Dimephosphone demonstrates a clear membrane-stabilizing effect, clinically manifesting as reduced inflammation and improved renal function.
- These findings suggest dimephosphone as a potential therapeutic agent for managing kidney inflammation and associated renal dysfunction.